drugset / Trial / NCT04111627

Exercise Plus Duloxetine for Knee Osteoarthritis

NCT04111627

NaSingle-groupOpen-labelTreatment

Summary

This study evaluates the addition of duloxetine to aerobic exercise in the treatment of symptomatic knee osteoarthritis and depressive symptoms in adults. All participants will receive the receive the treatment protocol, which will first be evaluated in terms of feasibility and then pilot tested.

Timeline

Start
2021-10-07
Primary completion
2025-08-11
Completion
2025-08-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule 60 mg
Subject Duloxetine Small molecule 90 mg